908
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Activity cliff clusters as a source of structure–activity relationship information

, , &

Bibliography

  • Maggiora GM. On outliers and activity cliffs – why QSAR often disappoints. J Chem Inf Model 2006;46(4):1535–5
  • Stumpfe D, Bajorath J. Exploring activity cliffs in medicinal chemistry. J Med Chem 2012;55(7):2932–42
  • Stumpfe D, Hu Y, Dimova D, et al. Recent progress in understanding activity cliffs and their utility in medicinal chemistry. J Med Chem 2014;57(1):18–28
  • Structure modification in chemical databases, in Chemoinformatics in Drug Discovery. Kenny PW, Sadowski J, Oprea TI. Editors Wiley-VCH; Weinheim, Germany: 2005. pp 271–85
  • Hu X, Hu Y, Vogt M, et al. MMP-cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs. J Chem Inf Model 2012;52(5):1138–45
  • Hu Y, Stumpfe D, Bajorath J. Advancing the activity cliff concept [v1; ref status: indexed, http://f1000r.es/1wf] F1000Res. 2013;2:199
  • Stumpfe D, de la Vega de León A, Dimova D, et al. Advancing the activity cliff concept, part II [v1; ref status: indexed, http://f1000r.es/34p] F1000Res. 2014;3:75
  • Gaulton A, Bellis LJ, Bento AP, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 2011;40:D1100–7
  • Stumpfe D, Dimova D, Bajorath J. Composition and topology of activity cliff clusters formed by bioactive compounds. J Chem Inf Model 2014;54(2):451–61
  • Dimova D, Stumpfe D, Bajorath J. A method for the evaluation of structure-activity relationship information associated with coordinated activity cliffs. J Med Chem 2014;57(15):6553–63
  • Dimova D, Stumpfe D, Bajorath J. Systematic assessment of coordinated activity cliffs formed by kinase inhibitors and detailed characterization of activity cliff clusters and associated SAR information. Eur J Med Chem 2015;90:414–27
  • Dimova D, Bajorath J. Extraction of structure-activity relationship information from activity cliff clusters via matching molecular series. Eur J Med Chem 2014;87:454–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.